Search by Drug Name or NDC

    NDC 00363-0708-26 childrens wal tap 2; 10; 5 mg/10mL; mg/10mL; mg/10mL Details

    childrens wal tap 2; 10; 5 mg/10mL; mg/10mL; mg/10mL

    childrens wal tap is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00363-0708
    Product ID 0363-0708_4127be67-e3a5-4b52-9e06-3ec66998fd4f
    Associated GPIs 50309903602000
    GCN Sequence Number 004698
    GCN Sequence Number Description phosphorated carbo(dext-fruct) SOLUTION ORAL
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 73710
    HICL Sequence Number 015060
    HICL Sequence Number Description PHOSPHORATED CARBOHYDRATE (DEXTROSE AND FRUCTOSE)
    Brand/Generic Generic
    Proprietary Name childrens wal tap
    Proprietary Name Suffix dm cough and cold
    Non-Proprietary Name Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 2; 10; 5
    Active Ingredient Units mg/10mL; mg/10mL; mg/10mL
    Substance Name BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Walgreen Company
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00363-0708-26 (00363070826)

    NDC Package Code 0363-0708-26
    Billing NDC 00363070826
    Package 1 BOTTLE in 1 CARTON (0363-0708-26) / 118 mL in 1 BOTTLE
    Marketing Start Date 2007-03-09
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 5e8495f7-bdc3-4d27-ad2a-9de4e463f7c7 Details

    Revised: 12/2018